Active immune therapy for the treatment of HIV infections.
Letvin
N L
NL
Harvard Medical School, New England Regional Primate Research Center, Southborough, MA 01772.
Chen
Z W
ZW
Yamamoto
H
H
Watanabe
M
M
D000818:Animals; D015704:CD4 Antigens / Q000276:immunology; D004195:Disease Models, Animal; D015683:Gene Products, gag / Q000276:immunology; D015658:HIV Infections / Q000276:immunology / Q000628:therapy*; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D007167:Immunotherapy / Q000379:methods*; D008253:Macaca mulatta; D002679:Pan troglodytes / Q000276:immunology; D011948:Receptors, Antigen, T-Cell; D011994:Recombinant Proteins / Q000276:immunology; D015302:Simian Immunodeficiency Virus / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D015704:CD4 Antigens; D015683:Gene Products, gag; D015395:Histocompatibility Antigens Class I; D011948:Receptors, Antigen, T-Cell; D011994:Recombinant Proteins